Fig. 2From: Establishment and validation of a prognostic risk classification for patients with stage T1-3N0M0 esophageal squamous cell carcinomaApplication of Esorisk to refine the risk assessment in patients with stage T1-3N0M0 esophageal squamous cell cancer in two cohorts. A The training cohort. B The external validation cohortBack to article page